Patient Association: Myeloma Patients Europe (MPE) (European Union): Difference between revisions

From Beacon
No edit summary
m (Update categories.)
Line 1: Line 1:
{{forpatients}}
<span style="display:none">forpatients</span>
Go back to [[European Union]] page
Go back to [[European Union]] page


Line 8: Line 8:
'''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access].
'''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access].


{{Blood}}
<span style="display:none">Blood</span>
{{Bone marrow}}
<span style="display:none">Bone marrow</span>
{{Lymph nodes}}
<span style="display:none">Lymph nodes</span>
{{Spleen}}
<span style="display:none">Spleen</span>
{{Leukemia}}
<span style="display:none">Leukemia</span>
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>

Revision as of 13:39, 2 December 2025

forpatients Go back to European Union page

Primary purpose: To educate, inform, and support member groups while advocating for the best research, treatment, and care across Europe.

Cancer areas of interest: C81-C96: Cancers of the blood and immune system.

Access to information: Click here to access.

Blood Bone marrow Lymph nodes Spleen Leukemia hasCancerType::C81-C96: Cancers of the blood and immune system